Keeping into consideration that those patients with a PCa grade group 3 could have an increased risk for eventual metastases ( 19 ) as well as a five-fold increased risk of PCa mortality compared to grade group 2 ( 20 ), we suggest to continue follow-up PSA-tests every 3 months and provide the results by telehealth. Here, KLK3 is linked to posterior cortical atrophy.